Biotech/ Biodefense Sector Trading Alert; (OTCBB: AEMD), (NASDAQ GM: DYSL), (NYSE Amex: PIP), (NasdaqGM: SIGA)
SIGA Technologies, Inc. (Nasdaq:SIGA) to report first quarter 2011 results
Category: Investment, Biotech
Ideas get bigger when you share them...
Visit this company: www.aethlonmedical.com
Point Roberts, WA - May 5, 2011 - Investorideas.com, a leader in investor sector research including Biotech and Biodefense Stocks issues a trading alert on biodefense stocks (OTCBB: AEMD), (NASDAQ GM: DYSL), (NYSE Amex: PIP), (AMEX: PLX and (NasdaqGM: SIGA).
Shares of Siga Technologies (NasdaqGM: SIGA ) moved higher in yesterday’s trading on higher than normal volume on rumors of a possible Biomedical Advanced Research and Development Authority (BARDA) contract . The stock is down in trading today trading at
$13.57 0.40 (2.86%) 11:57AM EDT, with an early high of $14.10.
SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, will report first quarter 2011 results on Thursday, May 5, 2011.
Management will host a conference call and simultaneous webcast to discuss the results of operations and provide an update on recent business developments at 4:30 P.M. ET on Thursday, May 5, 2011. Participants should call (877) 564-1219 (United States/Canada) or (973) 638-3429 (International) and request the SIGA call or provide confirmation code 63752611. A live broadcast of the call will be available on the Company's website at www.siga.com under the 'Events & Presentations' tab in the Investor Relations section.
Biotech/ Biodefense Stocks Sector Snapshot
- Aethlon Medical (OTCBB: AEMD) trading at $0812 - 0.09
- Dynasil Corporation (NASDAQ GM: DYSL) trading at $3.84, up 0.04 (1.05%)
- Emergent Biosolutions, Inc. Com (NYSE: EBS ) trading at $23.50, down 0.15 (0.63%) 12:02PM
- PharmAthene, Inc. (NYSE Amex: PIP) trading at $3.82 , down 0.02 (0.52%) 12:03PM EDT
- Protalix BioTherapeutics, Inc. (AMEX: PLX ) trading at$ 6.50, down 0.03 (0.46%) 12:08PM EDT
- Siga Technologies (NasdaqGM: SIGA ) trading at $13.57< down 0.40 (2.86%) 11:57AM EDT
- Dow 12,700.38 -23.20 -0.18%
- Nasdaq 2,845.27 +17.04 +0.60%
- S&P 500 1,347.66 +0.34 +0.03%
- 10 Yr Bond(%) 3.1860% -0.0370
- Oil 102.49 -6.75 -6.18%
- Gold 1,492.00 -22.90 -1.51%
Research more Biodfense stocks at Investorideas.com
Research Biotech Stocks atInvestorideas.com
Biotech/ Biodefense Company Snapshots ; Aethlon Medical (OTCBB: AEMD), Siga Technologies (NasdaqGM: SIGA )
Aethlon Medical (OTCBB: AEMD)
At Aethlon Medical, we create revolutionary devices to address infectious disease and cancer. Our devices are designed to be novel platform solutions that fill therapeutic voids or aid in disease diagnosis and monitoring.
Our Hemopurifier® is the first medical device to selectively target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. We recently discovered that our Hemopurifier® captures tumor-secreted exosomes that suppress the immune system of those afflicted with cancer. Prior to this discovery, a therapeutic strategy to directly inhibit or reverse the immunosuppressive destruction caused by exosomes did not exist in cancer care. By eliminating this mechanism, we believe our Hemopurifier® can fill an unmet clinical need and provide the benefit of an immune-based therapy without adding drug toxicity or interaction risks to established and emerging treatment strategies.
James A. Joyce
Visit the Aethlon Medical (OTCBB: AEMD) showcase page on Investorideas.com
Get added to the company’s news alerts:
Siga Technologies (NasdaqGM: SIGA )
SIGA Technologies is a pharmaceutical company specializing in the development and commercialization of therapeutic solutions for some of the most lethal disease causing pathogens in the world - smallpox, Ebola, dengue, Lassa fever and other dangerous viruses. Our business is to discover, develop, manufacture and successfully commercialize drugs to prevent and treat these high priority threats. Our mission is to disarm dreaded viral diseases and create robust, modern biodefense countermeasures. For more information, please visit SIGA's web site at www.siga.com.
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, including biotech stocks and biodefense stocks.
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. AETHLON MEDICAL INC(OTC BB: AEMD ) Showcase biotech, biodefense and defense stock on Investorideas.com ( $one thousand five hundred per month, $five thousand per month in 144 stock)Effective March 15, 2011
Aethlon Medical ( OTCBB:AEMD) :Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements.
800-665-0411 - firstname.lastname@example.org
Source - Investorideas.com
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Connect with Investorideas.com
Publish Your News - Send a release
Disclaimer: The following news is paid for and /or published as information only for our readers (175 top energy news).
Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp